Patient resources

Your implanted double lumen (Vortex®) port

Subcutaneous patient controlled pain relief (analgesia) to manage a sickle cell crisis

What is thalassaemia and how is it treated?

Hydroxycarbamide treatment plan for haemoglobin disorders

Please note that this leaflet should only be used if authorised by a member of the Sickle Cell and Thalassaemia Team

MGUS (Monoclonal Gammopathy of Uncertain Significance): how we follow you up

IVE (Ifosfamide, Etoposide and Epirubicin) chemotherapy treatment and stem cell collection

Low dose cytarabine (Low dose Ara C)

Your nurse specialist and the team caring for you (leukaemia and myelodysplastic syndromes)

Cyclophosphamide treatment and stem cell collection

G CSF and plerixafor treatment

Sickle cell disease and pregnancy – what you need to know

Please note that this leaflet should only be used if authorised by a member of the Sickle Cell Disease healthcare team.

Having a platelets function blood test

Understanding immune thrombocytopenia (ITP)

This leaflet should only be used as authorised by a member of the Haematology health care team.

Your nurse specialist (key worker) and the team that care for patients with a diagnosis of lymphoma or chronic lymphocytic leukaemia

Useful contacts for patients with myeloma

Your myeloma key worker (nurse specialist) and the team looking after you

Hydroxycarbamide treatment for haemoglobin disorders (children)

Please note that this leaflet should only be used if authorised by a member of the Sickle Cell and Thalassaemia Healthcare Team.

Understanding alpha thalassaemia

Please note that this leaflet should only be used as authorised by a member of the Haematology Healthcare Team.

Haematology helpline

Understanding supported self-management

Please be advised that you should ask for help by your Haematology team if you wanting to access this leaflet.